Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
2.
Cell Rep ; 42(8): 112927, 2023 Aug 29.
Article in English | MEDLINE | ID: mdl-37537841

ABSTRACT

Tumor relapse is linked to rapid chemoresistance and represents a bottleneck for cancer therapy success. Engagement of a reduced proliferation state is a non-mutational mechanism exploited by cancer cells to bypass therapy-induced cell death. Through combining functional pulse-chase experiments in engineered cells and transcriptomic analyses, we identify DPPA3 as a master regulator of slow-cycling and chemoresistant phenotype in colorectal cancer (CRC). We find a vicious DPPA3-HIF1α feedback loop that downregulates FOXM1 expression via DNA methylation, thereby delaying cell-cycle progression. Moreover, downregulation of HIF1α partially restores a chemosensitive proliferative phenotype in DPPA3-overexpressing cancer cells. In cohorts of CRC patient samples, DPPA3 overexpression acts as a predictive biomarker of chemotherapeutic resistance that subsequently requires reduction in its expression to allow metastatic outgrowth. Our work demonstrates that slow-cycling cancer cells exploit a DPPA3/HIF1α axis to support tumor persistence under therapeutic stress and provides insights on the molecular regulation of disease progression.

3.
Cell ; 184(13): 3426-3437.e8, 2021 06 24.
Article in English | MEDLINE | ID: mdl-33991487

ABSTRACT

We identified an emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant by viral whole-genome sequencing of 2,172 nasal/nasopharyngeal swab samples from 44 counties in California, a state in the western United States. Named B.1.427/B.1.429 to denote its two lineages, the variant emerged in May 2020 and increased from 0% to >50% of sequenced cases from September 2020 to January 2021, showing 18.6%-24% increased transmissibility relative to wild-type circulating strains. The variant carries three mutations in the spike protein, including an L452R substitution. We found 2-fold increased B.1.427/B.1.429 viral shedding in vivo and increased L452R pseudovirus infection of cell cultures and lung organoids, albeit decreased relative to pseudoviruses carrying the N501Y mutation common to variants B.1.1.7, B.1.351, and P.1. Antibody neutralization assays revealed 4.0- to 6.7-fold and 2.0-fold decreases in neutralizing titers from convalescent patients and vaccine recipients, respectively. The increased prevalence of a more transmissible variant in California exhibiting decreased antibody neutralization warrants further investigation.


Subject(s)
Antibodies, Neutralizing/immunology , COVID-19/immunology , COVID-19/transmission , SARS-CoV-2/genetics , Spike Glycoprotein, Coronavirus/immunology , Antibodies, Monoclonal/immunology , Antibodies, Viral/immunology , Humans , Mutation/genetics , Whole Genome Sequencing/methods
4.
medRxiv ; 2021 Mar 09.
Article in English | MEDLINE | ID: mdl-33758899

ABSTRACT

We identified a novel SARS-CoV-2 variant by viral whole-genome sequencing of 2,172 nasal/nasopharyngeal swab samples from 44 counties in California. Named B.1.427/B.1.429 to denote its 2 lineages, the variant emerged around May 2020 and increased from 0% to >50% of sequenced cases from September 1, 2020 to January 29, 2021, exhibiting an 18.6-24% increase in transmissibility relative to wild-type circulating strains. The variant carries 3 mutations in the spike protein, including an L452R substitution. Our analyses revealed 2-fold increased B.1.427/B.1.429 viral shedding in vivo and increased L452R pseudovirus infection of cell cultures and lung organoids, albeit decreased relative to pseudoviruses carrying the N501Y mutation found in the B.1.1.7, B.1.351, and P.1 variants. Antibody neutralization assays showed 4.0 to 6.7-fold and 2.0-fold decreases in neutralizing titers from convalescent patients and vaccine recipients, respectively. The increased prevalence of a more transmissible variant in California associated with decreased antibody neutralization warrants further investigation.

5.
J Infect Dis ; 224(6): 1015-1023, 2021 09 17.
Article in English | MEDLINE | ID: mdl-33528506

ABSTRACT

In 2019, the United States (US) experienced the highest number of measles importations and cases in the postelimination era. More than a quarter of imported cases entered the US through California. Measles surveillance efforts in California resulted in the identification of 26 importations, 6 outbreaks, and 72 cases in 2019. Only genotype B3 and D8 measles strains were detected. Genotype-specific differences were noted in the incidence of vaccine failures, hospitalizations, and severe complications among cases. A targeted whole genome sequencing approach provided higher-resolution discrimination between epidemiologically linked and sporadically introduced strains than conventional N450 sequencing. Our report underscores the importance of ensuring appropriate measles vaccination status, especially prior to international travel to measles-endemic regions, and highlights the value of a strong measles surveillance system in minimizing outbreaks and preserving measles elimination status in the US.


Subject(s)
Disease Outbreaks , Measles Vaccine/administration & dosage , Measles virus , Measles/epidemiology , Adolescent , Adult , Aged , California/epidemiology , Child , DNA-Directed RNA Polymerases , Female , Genotype , Humans , Male , Measles virus/genetics , Measles virus/immunology , Measles virus/isolation & purification , Middle Aged , Molecular Epidemiology , Phylogeny , Sequence Analysis, DNA , United States/epidemiology , Young Adult
7.
Virus Res ; 281: 197935, 2020 05.
Article in English | MEDLINE | ID: mdl-32194138

ABSTRACT

Despite high coverage with measles, mumps, and rubella vaccine in the United States, outbreaks of mumps occur in close contact settings such as schools, colleges, and camps. Starting in late 2015, outbreaks were reported from several universities, and by the end of 2017, greater than 13,800 cases had been reported nation-wide. In 2013, the CDC and the Association of Public Health Laboratories contracted four Vaccine Preventable Diseases Reference Centers (VPD-RCs) to perform real-time reverse transcription PCR (RT-qPCR) to detect mumps RNA in clinical samples and to determine the genotype. Twelve genotypes of mumps virus are currently recognized by the World Health Organization, and the standard protocol for genotyping requires sequencing the entire gene coding for the small hydrophobic (SH) protein. Phylogenetic analysis of the 1862 mumps samples genotyped from 2015 through 2017 showed that the overall diversity of genotypes detected was low. Only 0.8 % of the sequences were identified as genotypes C, H, J, or K, and 0.5 % were identified as vaccine strains in genotypes A or N, while most sequences (98.7 %) were genotype G. The majority of the genotype G sequences could be included into one of two large groups with identical SH sequences. Within genotype G, a small number of phylogenetically significant outlier sequences were associated with epidemiologically distinct chains of transmission. These results demonstrate that molecular and epidemiologic data can be used to track transmission pathways of mumps virus; however, the limited diversity of the SH sequences may be insufficient for resolving transmission in all outbreaks.


Subject(s)
Disease Outbreaks , Mumps virus/genetics , Mumps/epidemiology , Viral Proteins/genetics , Genetic Variation , Genotype , Humans , RNA, Viral/genetics , United States/epidemiology
8.
J Clin Microbiol ; 58(1)2019 12 23.
Article in English | MEDLINE | ID: mdl-31666366

ABSTRACT

Pacific Coast tick fever is a febrile illness associated with the bite of Dermacentor occidentalis and results from an infection due to the intracellular pathogen Rickettsia 364D (also known by the proposed name "Rickettsia philipii"). Current molecular methods for the detection of this pathogen rely on the amplification of a conserved spotted fever group rickettsial gene (ompA) followed by DNA sequencing of the amplicon to identify the species. This work describes the development of a Rickettsia 364D-specific TaqMan assay to simplify and accelerate the detection and identification processes. The assay demonstrated a sensitivity of 1 genomic copy per 4-µl sample and is highly specific for Rickettsia 364D. The utility of this assay for ecological and diagnostic samples was evaluated using banked specimens collected in a single-blind manner and yielded a clinical sensitivity and specificity of 100%. In conclusion, we describe the development and evaluation of a novel TaqMan real-time PCR assay for the detection and identification of Rickettsia 364D suitable for ecological and diagnostic applications.


Subject(s)
Real-Time Polymerase Chain Reaction , Rickettsia Infections/diagnosis , Rickettsia Infections/microbiology , Rickettsia/genetics , Tick-Borne Diseases/diagnosis , Tick-Borne Diseases/microbiology , Animals , Dermacentor/microbiology , Humans , Real-Time Polymerase Chain Reaction/methods , Real-Time Polymerase Chain Reaction/standards , Rickettsia Infections/transmission , Sensitivity and Specificity , Tick-Borne Diseases/transmission
9.
Emerg Infect Dis ; 25(8): 1594-1596, 2019 08.
Article in English | MEDLINE | ID: mdl-31310213

ABSTRACT

We implemented subgenomic and whole-genome sequencing to support the investigation of a large hepatitis A virus outbreak among persons experiencing homelessness, users of illicit drugs, or both in California, USA, during 2017-2018. Genotyping data helped confirm case-patients, track chains of transmission, and monitor the effectiveness of public health control measures.


Subject(s)
Hepatitis A virus/classification , Hepatitis A virus/genetics , Hepatitis A/epidemiology , Hepatitis A/virology , Molecular Typing , California/epidemiology , Disease Outbreaks , Genotype , Hepatitis A/history , Hepatitis A/transmission , Hepatitis A virus/immunology , Hepatitis A virus/isolation & purification , History, 21st Century , Humans , Public Health Surveillance , Viral Proteins/genetics , Whole Genome Sequencing
10.
J Med Entomol ; 55(6): 1555-1560, 2018 10 25.
Article in English | MEDLINE | ID: mdl-29982649

ABSTRACT

The Pacific Coast tick (Dermacentor occidentalis Marx, 1892) is one of the most widely distributed and frequently encountered tick species in California. This tick is the primary vector of an unclassified spotted fever group rickettsial pathogen, designated currently as Rickettsia 364D, the etiologic agent of a recently recognized tick-borne rickettsiosis known as Pacific Coast tick fever. Despite intensified interest in this pathogen, important questions remain regarding its taxonomic status and possible variations in genotype among different strains that could influence its pathogenicity. Only the extensively passaged prototypical isolate (strain 364-D) is widely available to rickettsiologists and public health scientists worldwide. To achieve a larger, more geographically diverse, and contemporary collection of strains, 1,060 questing adult D. occidentalis ticks were collected from 18 sites across six counties in northern and southern California in 2016 and 2017. Fourteen ticks (1.3%) yielded DNA of Rickettsia 364D and from these, 10 unique isolates from Lake and Orange counties were obtained. Additionally, Rickettsia rhipicephali was detected in 108 (10.2%) ticks, from which eight isolates were obtained, and Rickettsia bellii in six (0.6%), from which three isolates were obtained. The panel of recently acquired, low-passage strains of Rickettsia 364D derived from this study could enhance opportunities for investigators to accurately determine the taxonomic standing of this agent and to develop specific diagnostic assays for detecting infections with Rickettsia 364D in ticks and humans.


Subject(s)
Dermacentor/microbiology , Rickettsia/isolation & purification , Animals , California , Female , Male , Rickettsia/genetics
11.
Genome Announc ; 5(33)2017 Aug 17.
Article in English | MEDLINE | ID: mdl-28818890

ABSTRACT

We report here the full coding sequence of nine paramyxovirus genomes, including two full-length mumps virus genomes (genotypes G and H) and seven measles virus genomes (genotypes B3 and D4, D8, and D9), from respiratory samples of patients from California, Virginia, and Alabama obtained between 2010 and 2014.

12.
PLoS Negl Trop Dis ; 10(10): e0005020, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27706171

ABSTRACT

Rickettsia philipii (type strain "Rickettsia 364D"), the etiologic agent of Pacific Coast tick fever (PCTF), is transmitted to people by the Pacific Coast tick, Dermacentor occidentalis. Following the first confirmed human case of PCTF in 2008, 13 additional human cases have been reported in California, more than half of which were pediatric cases. The most common features of PCTF are the presence of at least one necrotic lesion known as an eschar (100%), fever (85%), and headache (79%); four case-patients required hospitalization and four had multiple eschars. Findings presented here implicate the nymphal or larval stages of D. occidentalis as the primary vectors of R. philipii to people. Peak transmission risk from ticks to people occurs in late summer. Rickettsia philipii DNA was detected in D. occidentalis ticks from 15 of 37 California counties. Similarly, non-pathogenic Rickettsia rhipicephali DNA was detected in D. occidentalis in 29 of 38 counties with an average prevalence of 12.0% in adult ticks. In total, 5,601 ticks tested from 2009 through 2015 yielded an overall R. philipii infection prevalence of 2.1% in adults, 0.9% in nymphs and a minimum infection prevalence of 0.4% in larval pools. Although most human cases of PCTF have been reported from northern California, acarological surveillance suggests that R. philipii may occur throughout the distribution range of D. occidentalis.


Subject(s)
Arachnid Vectors/microbiology , Dermacentor/microbiology , Rickettsia Infections/epidemiology , Rickettsia Infections/transmission , Rickettsia/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Antibodies, Bacterial/blood , California/epidemiology , Child , Child, Preschool , Female , Fever , Humans , Immunoglobulin G/blood , Larva/microbiology , Male , Middle Aged , Nymph/microbiology , Prevalence , Rickettsia/genetics , Rickettsia/immunology , Rickettsia/pathogenicity , Rickettsia Infections/diagnosis , Rickettsia Infections/microbiology , Young Adult
13.
Pediátr. Panamá ; 43(3): 18-24, Diciembre 2014.
Article in Spanish | LILACS | ID: biblio-848656

ABSTRACT

La encefalitis anti receptor N-metil-D-aspartato (NMDAR) es una enfermedad autoinmune que debe sospecharse cuando un paciente se presenta con una combinación de síntomas psiquiátricos, disfunción autonómica, movimientos anormales y descompensación neurológica. La importancia de la sospecha clínica y la comprobación del diagnóstico es crucial ya que, a pesar de la gravedad del padecimiento, los pacientes a menudo mejoran luego de una larga estadía intrahospitalaria con inmunoterapia y atención multidisciplinaria. Presentamos un escolar de 11 años , febril con historia de debilidad generalizada, somnolencia, hiporexia, desorientación, hipología de miembros inferiores, que evoluciona hacia agitación psicomotora, discinesias, alteraciones de la conducta, del habla y deterioro neurológico progresivo.


The encephalitis anti NMDA receptor (N-Methyl-D-Aspartate Receptor) is an autoimmune disease, that should be suspected when a patient presents with a combination psychiatric symptoms, autonomic dysfunction, abnormal movements and neurological decompensation. The importance of clinical suspicious and verification of diagnosis is crucial because, despite the severity of the disease, patients often improve after a long hospital stay with immunotherapy and multidisciplinary care. We report a 11 years old male, afebrile with a history of generalized weakness, drowsiness, decreased appetite, disorientation, lower limb hypotonia, psychomotor agitation progressing to, dyskinesia, abnormal behavior, speech and progressive neurological deterioration.

14.
Pediatr Infect Dis J ; 32(9): 1036-9, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23594588

ABSTRACT

We describe the clinical course of the first 3 pediatric cases infected with Rickettsia spp. 364D. Although the pathogen was identified in California ticks decades ago, only recently have human cases been documented. Clinical features are generally mild, characterized by eschar, fever, headache, malaise and lymphadenopathy. Antigenic similarity among rickettsiae leads to cross-reactive antibody responses; definitive diagnosis requires molecular methods.


Subject(s)
Rickettsia Infections/epidemiology , Rickettsia Infections/pathology , Rickettsia/classification , Rickettsia/isolation & purification , Tick-Borne Diseases/epidemiology , Tick-Borne Diseases/pathology , Adolescent , Child , Female , Humans , Male , Rickettsia Infections/microbiology , Tick-Borne Diseases/microbiology
15.
Nat Prod Res ; 27(4-5): 500-5, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22746970

ABSTRACT

Acetylcholinesterase (AChE) inhibitors have been used for the symptomatic treatment of Alzheimer's disease. Eleven whole plants from Panama belonging to the Lycopodiaceae family have been screened for their anticholinesterase inhibitory and antioxidant activities by a thin-layer chromatography (TLC) bioautography method. Of these, only Lycopodium clavatum subsp. clavatum showed strong AChE inhibition. Seven plant extracts showed moderate inhibition, two of them, Huperzia cf chamaeleon and Huperzia reflexa, also possessed an antioxidant activity. This is the first report of anticholinesterase and antioxidant activities in these two native plants. Additionally, alkaloid extracts of the Lycopodiaceae plants were also analysed by TLC and LC-MS to identify the well-known AchE inhibitor, huperzine A. Two plants, H. cf chamaeleon and H. reflexa var. minor, showed the presence of huperzine.


Subject(s)
Cholinesterase Inhibitors/chemistry , Lycopodiaceae/chemistry , Alkaloids/chemistry , Antioxidants/chemistry , Chromatography, Thin Layer , Lycopodium/chemistry , Mass Spectrometry , Panama , Plant Extracts/chemistry , Sesquiterpenes/chemistry
16.
Pharm Biol ; 48(9): 988-93, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20731549

ABSTRACT

CONTEXT: This is the first comprehensive study of the acetylcholinesterase (AChE) inhibitory activity of species of the family Amaryllidaceae and 13 related families from Panama. OBJECTIVE: Exploration of the potential sources of AChE inhibitors with radical scavenging activity from Amaryllidaceae and 13 related families from Panama. MATERIALS AND METHODS: The studied plants were screened with anti-acetylcholinesterase bioautographic and DPPH free radical scavenging assays. RESULTS: From the 57 plants studied, eight (14%) showed strong inhibition of AChE, and 29 (51%) plants showed moderate inhibition of AChE. DISCUSSION AND CONCLUSION: Sagittaria lancifolia L. (Alismataceae), Crinum jagus (Thomps.) (Amaryllidaceae), Crinum x amabile Donn (Amaryllidaceae), Crinum zeylanicum (L.) L. (Amaryllidaceae), Crocosmia x crocosmiiflora (Lemoine ex Anonymous) N.E. Br. (Iridaceae), Sisyrinchium tinctorium Kunth (Iridaceae), Agapanthus praecox subsp. orientalis (F.M. Leight.) F.M. Leight. (Liliaceae), and Xyris jupicai Rich. (Xyridaceae) were the most active plants, inhibiting AChE at 100 microg on the TLC bioautographic method for the detection of acetylcholinesterase inhibitors. Out of the eight most active plants, two plants, Crinum zeylanicum (L.) L. and Xyris jupicai Rich., showed antioxidant activity.


Subject(s)
Cholinesterase Inhibitors/chemistry , Drug Discovery , Liliaceae/chemistry , Plant Extracts/chemistry , Plants, Medicinal/chemistry , Alismataceae/chemistry , Alkaloids/analysis , Drug Evaluation, Preclinical , Free Radical Scavengers/chemistry , Iridaceae/chemistry , Panama
17.
Pharm Biol ; 48(5): 545-53, 2010 May.
Article in English | MEDLINE | ID: mdl-20645798

ABSTRACT

In order to explore rationally the medical potential of the plant biodiversity of the Central and South American region as a source of novel antiparasitic molecules, a multinational Organization of American States (OAS) project, which included the participation of multidisciplinary research centers from Argentina, Bolivia, Colombia, Costa Rica, Guatemala, Nicaragua and Panama, was carried out during the period 2001-2004. This project aimed at screening organic plant extracts for antitrypanosomal, antileishmanial and antimalarial activities and subsequently isolating and characterizing bioactive molecules. Plants for antiparasitic screening were selected from a database of ethnomedical uses of Latin American plants (PlanMedia) based on the amount of biological and chemical information available in the literature. We report here the evaluation of 452 extracts from 311 plant species in vitro screens against Plasmodium falciparum, Leishmania mexicana, and Trypanosoma cruzi. Out of 311 species tested, 17 plants (5.4%) showed antiparasitic activities at IC(50) values < or = 10 microg/mL. The most active plants were Acnistus arborescens (L.) Schltdl. (Solanaceae) (leaf, EtOH, IC(50): 4 microg/mL) Monochaetum myrtoideum Naudin (Melastomataceae) (leaf, MeOH, IC(50): 5 microg/mL) and Bourreria huanita (Lex.) Hemsl. (Boraginaceae) (branch, EtOH, IC(50): 6 microg/mL). These were selectively active against P. falciparum, L. mexicana and T. cruzi, respectively.


Subject(s)
Antimalarials/therapeutic use , Antiparasitic Agents/therapeutic use , Chagas Disease , Leishmaniasis , Malaria , Plant Extracts/therapeutic use , Antimalarials/isolation & purification , Antiparasitic Agents/isolation & purification , Chagas Disease/drug therapy , Drug Evaluation, Preclinical/methods , Humans , Latin America , Leishmaniasis/drug therapy , Malaria/drug therapy , Plant Extracts/isolation & purification , Plants , Random Allocation
18.
Nat Prod Commun ; 4(10): 1323-6, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19911564

ABSTRACT

Seventy-six plant extracts from the Panamanian flora have been screened for acetylcholinesterase (AChE) inhibitors by thin-layer chromatography (TLC) bioautography. The most promising extracts with AChE inhibitory and free radical scavenging activities at 100 microg were those of Tabernaemontana panamensis (Markgr., Boiteau & L. Allorge) Leeuwenb., Pentagonia macrophylla Benth., and Warszewiczia coccinea (Vahl) Klotzsch. Bioguided fractionation of W. coccinea stem extract afforded two triterpenes, 3beta,6beta,19alpha-trihydroxy-urs-12-en-28-oic acid (1) and 3beta,6beta-dihydroxy-olean-12-en-28-oic acid (sumaresinolic acid) (2), with AChE inhibitory activity. Their structures were determined by spectroscopic methods. This is the first report of these bioactive triterpenes in W. coccinea.


Subject(s)
Cholinesterase Inhibitors/chemistry , Oleanolic Acid/analogs & derivatives , Rubiaceae/chemistry , Triterpenes/chemistry , Cholinesterase Inhibitors/pharmacology , Chromatography, Thin Layer/methods , Oleanolic Acid/chemistry , Oleanolic Acid/pharmacology , Triterpenes/pharmacology
19.
Nat Prod Commun ; 4(10): 1401-6, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19911579

ABSTRACT

The composition and biological activity of the essential oils from leaves, fruits, stems and bark of Protium confusum are reported for the first time. Forty-six to sixty-three constituents were identified ranging from 73.8% to 98.5% of the samples. Limonene (60.2%) was the main component in the fruit oil, whereas spathulenol (19.3%), beta-caryophyllene oxide (14.1%) and beta-caryophyllene (8.0%) reached the highest percentages in the oil from leaves. The volatile oils from bark and stems showed the same major constituents: p-cymen-8-ol (14.4% and 6.1%, respectively), spathulenol (9.5% and 9.0% respectively), and hexadecanoic acid (8.4% and 7.8%, respectively). The composition of the essential oils differed significantly from those of previously investigated Protium species. Three out of the four samples exhibited antibacterial activity against Staphylococcus aureus and Mycobacterium smegmatis, the one from leaves being the most active, with MIC values of 62.5 microg/mL in both cases. No activity against Candida albicans was detected. The bark oil showed the highest larvicidal activity against Aedes aegypti (LC100 = 125 microg/mL).


Subject(s)
Anti-Bacterial Agents/pharmacology , Burseraceae/chemistry , Insecticides/pharmacology , Oils, Volatile/chemistry , Plant Oils/chemistry , Aedes/drug effects , Animals , Anti-Bacterial Agents/chemistry , Insecticides/chemistry , Larva/drug effects , Microbial Sensitivity Tests , Plant Components, Aerial/chemistry
20.
Ann Neurol ; 65(3): 257-67, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19334059

ABSTRACT

OBJECTIVE: Virus infections are the most common causes of encephalitis, a syndrome characterized by acute inflammation of the brain. More than 150 different viruses have been implicated in the pathogenesis of encephalitis; however, because of limitations with diagnostic testing, causative factors of more than half of the cases remain unknown. METHODS: To investigate whether human herpesvirus-6 (HHV-6) is a causative agent of encephalitis, we examined for evidence of virus infection by determining the presence of viral sequence using polymerase chain reaction and assessed HHV-6 antibody reactivity in the cerebrospinal fluid of encephalitis patients with unknown cause. In a cohort study, we compared virus-specific antibody levels in cerebrospinal fluid samples of patients with encephalitis, relapsing-remitting multiple sclerosis, and other neurological diseases. RESULTS: Our results demonstrated increased levels of HHV-6 IgG, as well as IgM levels, in a subset of encephalitis patients compared with other neurological diseases. Moreover, cell-free viral DNA that is indicative of active infection was detected in 40% (14/35) of encephalitis patients, whereas no amplifiable viral sequence was found in either relapsing-remitting MS or other neurological diseases patients. In addition, a significant correlation between polymerase chain reaction detection and anti-HHV-6 antibody response was also demonstrated. INTERPRETATION: Collectively, these results suggested HHV-6 as a possible pathogen in a subset of encephalitis cases.


Subject(s)
Encephalitis, Viral/cerebrospinal fluid , Herpesvirus 6, Human/isolation & purification , Roseolovirus Infections/cerebrospinal fluid , Adolescent , Adult , Antibodies, Viral/cerebrospinal fluid , Brain/pathology , Brain/virology , Case-Control Studies , Cell Line , Child , Child, Preschool , Cohort Studies , DNA, Viral/cerebrospinal fluid , DNA, Viral/chemistry , Encephalitis, Viral/pathology , Female , Herpesvirus 6, Human/genetics , Herpesvirus 6, Human/immunology , Humans , Immunoassay , Immunoglobulin G/cerebrospinal fluid , Immunoglobulin M/cerebrospinal fluid , Male , Middle Aged , Roseolovirus Infections/pathology , Sequence Analysis, DNA , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...